Subsequently, the ultrasonography diaphragm amplitude movement was evaluated in 10-week-old mdx mice receiving the intravenous administration of AAV-Flag-micro-dystrophin (AAV-μDys), one of the most promising therapeutic strategies for DMD. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.